Chonghui Xu
Overview
Explore the profile of Chonghui Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang J, Fu M, Xu C, Xue B, Zhou A, Chen S, et al.
Virol Sin
. 2023 Jun;
38(5):767-777.
PMID: 37328107
Tick-borne encephalitis virus (TBEV) is an important tick-borne pathogen that poses as a serious public health concern. The coverage and immunogenicity of the currently available vaccines against TBEV are relatively...
2.
Liu C, Zhao K, Chen Y, Yao Y, Tang J, Wang J, et al.
J Virol
. 2023 May;
97(5):e0058023.
PMID: 37166302
Hepatitis B virus (HBV) infection affects hepatic metabolism. Serum metabolomics studies have suggested that HBV possibly hijacks the glycerol-3-phosphate (G3P) shuttle. In this study, the two glycerol-3-phosphate dehydrogenases (GPD1 and...
3.
Tang J, Xu C, Fu M, Liu C, Zhang X, Zhang W, et al.
J Med Virol
. 2023 Feb;
95(3):e28610.
PMID: 36840407
Tick-borne encephalitis virus (TBEV) is the causative agent of a potentially fatal neurological infection in humans. Investigating virus-host interaction is important for understanding the pathogenesis of TBEV and developing effective...
4.
Tian L, Liu Q, Pei R, Chen Y, Xu C, Tang J, et al.
Virol Sin
. 2022 Jul;
37(5):695-703.
PMID: 35781091
Several variants of concern (VOCs) have emerged since the WIV04 strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first isolated in January 2020. Due to mutations in the...
5.
Xu C, Chen J, Chen X
Front Microbiol
. 2021 Nov;
12:740464.
PMID: 34803956
Hepatitis viruses are primary causative agents of hepatitis and represent a major source of public health problems in the world. The host innate immune system forms the first line of...
6.
Xu C, Tang J, Yang Q, Zhao H, Liu Y, Cao J, et al.
J Biol Chem
. 2021 Nov;
297(6):101380.
PMID: 34740611
Histone deacetylase 5 (HDAC5) has been reported to have a strong regulatory function in the proinflammatory response, but the mechanism is still unknown. Here, we identified HDAC5 as a positive...
7.
Yang Q, Tang J, Xu C, Zhao H, Zhou Y, Wang Y, et al.
J Mol Cell Biol
. 2020 Aug;
12(12):933-945.
PMID: 32770227
Protein modification by small ubiquitin-like modifier (SUMO) is an important regulatory mechanism for multiple cellular processes. Although the canonical pathway involving the ubiquitylation or phosphorylation of IκBα has been well...
8.
Zhou Y, Wang Q, Yang Q, Tang J, Xu C, Gai D, et al.
Virol Sin
. 2018 Oct;
33(5):418-428.
PMID: 30328580
Histone deacetylase (HDAC) inhibitors show clinical promise for the treatment of cancers, including hepatocellular carcinoma (HCC). In this study, we investigated the effect of HDAC inhibitor treatment on hepatitis C...
9.
Yang Q, Tang J, Pei R, Gao X, Guo J, Xu C, et al.
J Mol Cell Biol
. 2018 May;
11(2):158-169.
PMID: 29800227
Class II HDACs, such as HDAC4, are critical regulators of the immune response in various immune cells; however, its role in innate immunity remains largely unknown. Here, we report that...
10.
Wang R, Ouyang Y, Xu C, Yi N, Jiang J, Deng W, et al.
Org Biomol Chem
. 2017 Jan;
15(4):796-800.
PMID: 28045175
A novel hypervalent iodine-triggered hydroamination of homopropargyl sulfonamides with copper halides to obtain dihalo-2,3-dihydropyrroles was efficiently developed. The reaction can provide access to chloro/bromo-cyclization extended from iodocyclization to prepare potentially...